A detailed history of Virtu Financial LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 6,019 shares of HROW stock, worth $211,146. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,019
Holding current value
$211,146
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$20.85 - $46.47 $125,496 - $279,702
6,019 New
6,019 $271,000
Q1 2023

May 01, 2023

BUY
$13.84 - $21.46 $218,256 - $338,424
15,770 New
15,770 $334,000
Q3 2021

Nov 12, 2021

SELL
$6.99 - $10.6 $104,346 - $158,236
-14,928 Closed
0 $0
Q2 2021

Sep 17, 2021

BUY
$6.68 - $11.07 $99,719 - $165,252
14,928 New
14,928 $139,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $950M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.